CV Science

Natalia Alencar de Pinho PhD, Epidemiology and Public Health

Course and current status

Current position

Tenured research scientist (CRCN) since 2024 at the Centre for Epidemiology and Public Health (CESP), Inserm UMR 1018, Villejuif, France.

Previous positions

01/2022-09/2024 Associated research scientist at the Centre for Epidemiology and Public Health (CESP), Inserm UMR 1018, Villejuif, France

07/2022-12/2022 Post-doctoral fellow at the Bordeaux Population Health Research Center, Inserm UMR1219, Bordeaux, France

01/2019-06/2022 Post-doctoral fellow at the Centre for Epidemiology and Public Health (CESP), Inserm UMR 1018, Villejuif, France

Education

2019 PhD in Public Health, Epidemiology, Université Paris-Saclay, France

2015 Master Research in Public Health - Epidemiology, Université Paris-Sud, France

2013 Master in Adult Healthcare Nursing, University of São Paulo, Brazil

2008 Advanced practices in nephrology nursing, Univ Fédérale de São Paulo, Brazil

2005 Registered Nurse, University of São Paulo, Brazil (2012, equivalence in France)

Supervision

3 PhD candidates, 10 Master students, 7 project managers and biostatisticiens

Scientific Network and Collaborations

Epidemiology committee of the French-speaking Society of Nephrology, Dialysis, and Transplantation, since 2022

CKD Prognosis Consortium, since 2022

CKDopps consortium, since 2019 (steering committee, since 2023)

International Society of Nephrology - International Network of CKD cohort studies, since 2016 (deputy chair, since 2025)

CKD-REIN consortium, since 2016 (PI since 2023)

National registry of kidney replacement therapy (REIN), since 201

Scientific summary

Epidemiologist at the Clinical Epidemiology team of the Centre for Epidemiology and Public Health (CESP, Inserm), my reseach is focused on two areas of chronic kidney disease (CKD) epidemiology. The first one is the identification of risk factors and biomarkers of disease progression, complications, and treatment responsiveness in CKD. The second one is real-life assessment of clinical practices associated with an improved transition to kidney replacement therapy, improved survival and health-related quality of life, reduced hospital morbidity and heath care burden.

Principal investigator of the CKD-REIN (Chronic Kidney Disease- Renal Epidemiology Network) cohort study, I also contribute to the steering committees of the CKD Outcomes and Practice Patterns Study (CKDopps), and the International Society of Nephrology - iNET-CKD (International Network of CKD cohort studies).